Clinical trial
Suramin in Treating Patients With Recurrent Bladder Cancer
NCT00006476 · Cancer Research UK, Other · Completed
Key facts
| NCT number | NCT00006476 |
|---|---|
| Title | Suramin in Treating Patients With Recurrent Bladder Cancer |
| Official title | A Phase I Study of Intravesicular Suramin in Recurrent Superficial Bladder Cancer |
| Lead sponsor | Cancer Research UK, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure |
| Interventions | suramin, conventional surgery |
| Enrollment | 15 |
| Start date | Oct 1, 2000 |
| Completion | Oct 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: